Glyka MR 30mg Modified Release Tablets contain gliclazide, a prescription sulfonylurea used to improve blood glucose control in adults with type 2 diabetes. The modified-release formulation gradually delivers the medicine while stimulating insulin secretion from the pancreas.
Active Ingredient: Gliclazide 30mg
Used For: Management of blood glucose levels in adults with type 2 diabetes mellitus.
Medicine Type: Prescription modified-release sulfonylurea tablets.
This product is a prescription-only medicine and should be used only as directed by a licensed healthcare professional. Always follow your doctor's recommendations and the instructions on your prescription label.
Take the tablets exactly as prescribed.
Swallow the modified-release tablet with water.
Follow the meal schedule and glucose-monitoring plan recommended by your healthcare professional.
Do not change or stop treatment without medical advice.
Continue any recommended blood glucose monitoring.
Do not share this medicine with others.
Use only for the condition for which it was prescribed.